Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Oncothyreon to Present at Wedbush Securities Life Sciences Management Access Conference



 Oncothyreon to Present at Wedbush Securities Life Sciences Management Access
                                  Conference

PR Newswire

SEATTLE, Aug. 6, 2013

SEATTLE, Aug. 6, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced
today that Julie Eastland, Chief Financial Officer and Vice President,
Corporate Development, will present at the Wedbush Securities Life Sciences
Management Access Conference in New York on Tuesday, Aug. 13, 2013 at 1:55
p.m. Eastern.

A live and archived webcast of the presentation will be accessible by visiting
the Oncothyreon website www.oncothyreon.com under the "News & Events" section.

About Oncothyreon

Oncothyreon is  a biotechnology  company specializing  in the  development  of 
innovative therapeutic  products for  the treatment  of cancer.  Oncothyreon's 
goal is to  develop and  commercialize novel synthetic  vaccines and  targeted 
small molecules that have the potential  to improve the lives and outcomes  of 
cancer patients. For more information, visit www.oncothyreon.com.

SOURCE Oncothyreon Inc.

Contact:

Investor and Media Relations Contact: 
Julie Rathbun
Rathbun Communications
206-769-9219
ir@oncothyreon.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement